George Clinical is a leading provider of oncology trial, scientific, and operational solutions throughout North America and the Asia-Pacific.
As a leader in the design and delivery of care-based, oncology research, George Clinical has access to significant global investigator networks, experienced project teams, oncology experts, and scientific leaders to design and deliver oncology trials, with the latest immunotherapies, to the highest scientific standards. By accessing some of the world’s most experienced medical, scientific and operational teams in oncology research, George Clinical is uniquely placed to meet the increasingly complex and specialized demands of modern oncology research, and as such demonstrate product value in terms of clinical effectiveness, specialized cohorts and tolerability.
Exceptional medical, scientific and operational expertise makes George Clinical an ideal partner for clinical trials throughout North America, the United States and the Asia-Pacific.
Our expertise in oncology services include:
George Clinical’s extensive experience in oncology trials, provides sponsors with the confidence that your oncology trial will be delivered on time, on budget and to the highest scientific standards.
Our clinical trial services in oncology clinical trials include:
Primary research interests include breast cancer, supportive care and developmental therapeutics. Recently involved with genomic profiling of advanced cancer. Interested in visionary approaches to clinical research and oncology science. Divides his time between individual patients in the clinic and conducting clinical research trials and programmatic development.
Expertise in clinical trials in oncology, with a focus on immune therapies in solid tumors and melanoma. Has collaborated and participated on advisory boards with many of the nation’s thought leaders and top experts in the field. Involved in research that can improve treatment for cancer patients by targeting therapy in a more personalized fashion based on immune markers and aberrations in cancer genetics.